External validation of risk prediction model M4 in an Australian population: Rationalising the management of pregnancies of unknown location.


Journal

The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027

Informations de publication

Date de publication:
12 2020
Historique:
received: 19 08 2019
accepted: 08 05 2020
pubmed: 17 6 2020
medline: 16 2 2021
entrez: 16 6 2020
Statut: ppublish

Résumé

The prediction model M4 can successfully classify pregnancy of unknown location (PUL) into a low- or high-risk group in developing ectopic pregnancy. M4 was validated in UK centres but in very few other countries outside UK. To validate the M4 model's ability to correctly classify PULs in a cohort of Australian women. A retrospective analysis of women classified with PUL, attending a Sydney-based teaching hospital between 2006 and 2018. The reference standard was the final characterisation of PUL: failed PUL (FPUL) or intrauterine pregnancy (IUP; low risk) vs ectopic pregnancy (EP) or persistent PUL (PPUL; high risk). Each patient was entered into the M4 model calculator and an estimated risk of FPUL/IUP or EP/PPUL was recorded. Diagnostic accuracy of the M4 model was evaluated. Of 9077 consecutive women who underwent transvaginal sonography, 713 (7.9%) classified with a PUL. Six hundred and seventy-seven (95.0%) had complete study data and were included. Final outcomes were: 422 (62.3%) FPULs, 150 (22.2%) IUPs, 105 (15.5%) EPs and PPULs. The M4 model classified 455 (67.2%) as low-risk PULs of which 434 (95.4%) were FPULs/IUPs and 21 (4.6%) were EPs or PPULs. EPs/PPULs were correctly classified with sensitivity of 80.0% (95% CI 71.1-86.5%), specificity of 75.9% (95% CI 72.2-79.3%), positive predictive value of 37.8% (95% CI 33.8-42.1%) and negative predictive value of 95.3% (95% CI 93.1-96.9%). We have externally validated the prediction model M4. It classified 67.2% of PULs as low risk, of which 95.4% were later characterised as FPULs or IUPs while still classifying 80.0% of EPs as high risk.

Sections du résumé

BACKGROUND
The prediction model M4 can successfully classify pregnancy of unknown location (PUL) into a low- or high-risk group in developing ectopic pregnancy. M4 was validated in UK centres but in very few other countries outside UK.
AIM
To validate the M4 model's ability to correctly classify PULs in a cohort of Australian women.
MATERIALS AND METHODS
A retrospective analysis of women classified with PUL, attending a Sydney-based teaching hospital between 2006 and 2018. The reference standard was the final characterisation of PUL: failed PUL (FPUL) or intrauterine pregnancy (IUP; low risk) vs ectopic pregnancy (EP) or persistent PUL (PPUL; high risk). Each patient was entered into the M4 model calculator and an estimated risk of FPUL/IUP or EP/PPUL was recorded. Diagnostic accuracy of the M4 model was evaluated.
RESULTS
Of 9077 consecutive women who underwent transvaginal sonography, 713 (7.9%) classified with a PUL. Six hundred and seventy-seven (95.0%) had complete study data and were included. Final outcomes were: 422 (62.3%) FPULs, 150 (22.2%) IUPs, 105 (15.5%) EPs and PPULs. The M4 model classified 455 (67.2%) as low-risk PULs of which 434 (95.4%) were FPULs/IUPs and 21 (4.6%) were EPs or PPULs. EPs/PPULs were correctly classified with sensitivity of 80.0% (95% CI 71.1-86.5%), specificity of 75.9% (95% CI 72.2-79.3%), positive predictive value of 37.8% (95% CI 33.8-42.1%) and negative predictive value of 95.3% (95% CI 93.1-96.9%).
CONCLUSIONS
We have externally validated the prediction model M4. It classified 67.2% of PULs as low risk, of which 95.4% were later characterised as FPULs or IUPs while still classifying 80.0% of EPs as high risk.

Identifiants

pubmed: 32538482
doi: 10.1111/ajo.13201
doi:

Substances chimiques

Chorionic Gonadotropin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

928-934

Informations de copyright

© 2020 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Références

Barnhart K, van Mello NM, Bourne T et al. Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome. Fertil Steril 2011; 95(3): 857-866.
Van Mello NM, Mol F, Opmeer BC et al. Diagnostic value of serum hCG on the outcome of pregnancy of unknown location: a systematic review and meta-analysis. Hum Reprod Update 2012; 18: 603-617.
Kirk E, Condous G, Bourne T. Pregnancies of unknown location. Best Pract Res Clin Obstet Gynaecol 2009; 23: 493-499.
Condous G, Timmerman D, Goldstein S et al. Pregnancies of unknown location: consensus statement. Ultrasound Obstet Gynecol 2006; 28(2): 121-122.
Kirk E, Papageorghiou AT, Condous G et al. The diagnostic effectiveness of an initial transvaginal scan in detecting ectopic pregnancy. Hum Reprod 2007; 22(11): 2824-2828.
Kirk E, Bottomley C, Bourne T. Diagnosing ectopic pregnancy and current concepts in the management of pregnancy of unknown location. Hum Reprod Update 2014; 20: 250-261.
Condous G, Kirk E, Lu C et al. Diagnostic accuracy of varying discriminatory zones for the prediction of ectopic pregnancy in women with a pregnancy of unknown location. Ultrasound Obstet Gynecol 2005; 26: 770-775.
Guha S, Ayim F, Ludlow J et al. Triaging pregnancies of unknown location: the performance of protocols based on single serum progesterone or repeated serum hCG levels. Hum Reprod 2014; 29(5): 938-945.
Van Calster B, Bobdiwala S, Guha S et al. Managing pregnancy of unknown location based on initial serum progesterone and serial serum hCG: development and validation of a two-step triage protocol. Ultrasound Obstet Gynecol 2016; 48: 642-649.
Condous G, Van Calster B, Kirk E et al. Prospective cross-validation of three methods of predicting failing pregnancies of unknown location. Hum Reprod 2007; 22(4): 1156-1160.
Van Calster B, Abdallah Y, Guha S et al. Rationalizing the management of pregnancies of unknown location: temporal and external validation of a risk prediction model on 1962 pregnancies. Hum Reprod 2013; 28(3): 609-616.
Barnhart KT, Sammel MD, Appleby D et al. Does a prediction model for pregnancy of unknown location developed in the UK validate on a US population? Hum Reprod 2010; 25(10): 2434-2440.
Fistouris J, Bergh C, Strandell A. Classification of pregnancies of unknown location according to four different hCG-based protocols. Hum Reprod 2016; 31(10): 2203-2211.
Bobdiwala S, Saso S, Verbakel JY et al. Diagnostic protocols for the management of pregnancy of unknown location: a systematic review and meta-analysis. BJOG 2019; 126(2): 190-198.
Bobdiwala S, Guha S, Van Calster B et al. The clinical performance of the M4 decision support model to triage women with a pregnancy of unknown location as at low or high risk of complications. Hum Reprod 2016; 31(7): 1425-1435.
Nadim B, Infante F, Lu C et al. The morphological ultrasound types known as 'blob' and 'bagel' signs should be reclassified from probable to definite ectopic pregnancy. Ultrasound Obst Gynecol 2018; 51: 543-549.
Nadim B, Leonardi M, Infante F et al. Rationalizing the management of pregnancies of unknown location: diagnostic accuracy of human chorionic gonadotropin ratio-based decision tree compared with the risk prediction model M4. Acta Obstet Gynecol Scand 2020; 99: 381-390.

Auteurs

Batool Nadim (B)

Acute Gynaecology, Early Pregnancy and Advanced Endoscopic Surgery Unit, Nepean Hospital, Nepean Clinical School University of Sydney, Sydney, New South Wales, Australia.

Mathew Leonardi (M)

Acute Gynaecology, Early Pregnancy and Advanced Endoscopic Surgery Unit, Nepean Hospital, Nepean Clinical School University of Sydney, Sydney, New South Wales, Australia.

Nicole Stamatopoulos (N)

Acute Gynaecology, Early Pregnancy and Advanced Endoscopic Surgery Unit, Nepean Hospital, Nepean Clinical School University of Sydney, Sydney, New South Wales, Australia.

Shannon Reid (S)

Department of Obstetrics and Gynaecology, Liverpool Hospital, Sydney, New South Wales, Australia.

George Condous (G)

Acute Gynaecology, Early Pregnancy and Advanced Endoscopic Surgery Unit, Nepean Hospital, Nepean Clinical School University of Sydney, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH